Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A PHASE 1B STUDY TO ASSESS THE SAFETY AND TOLERABILITY OF ZN-C5 IN CHINESE SUBJECTS WITH ADVANCED BREAST CANCER

NCT04852419 is registered in ClinicalTrials.gov with Zentera Therapeutics HK Limited as lead sponsor.

NCT NCT04852419
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04852419 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A PHASE 1B STUDY TO ASSESS THE SAFETY AND TOLERABILITY OF ZN-C5 IN CHINESE SUBJECTS WITH ADVANCED BREAST CANCER
Lead sponsor
Zentera Therapeutics HK Limited
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2021
Completion date
June 23, 2022
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms